Now showing items 119-138 of 414

      EAP and COVID-19: Actively working to be more antiracist in the employee assistance field [1]
      Editorial. COVID-19 and spinal surgery [1]
      The effect of COVID-19 stay-at-home order and campus closure on the prevalence of acute respiratory infection symptoms in college campus cohorts [1]
      Effect of SARS-CoV-2 infection in pregnancy on maternal and neonatal outcomes in Africa: An AFREhealth call for evidence through multicountry research collaboration [1]
      The Effect of the COVID-19 Pandemic on Hip and Knee Arthroplasty Patients in the United States: A Multicenter Update to the Previous Survey [1]
      Effects of magnesium ions on recombinant human furin: Selective activation of hydrolytic activity upon substrates derived from virus envelope glycoprotein [1]
      Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [1]
      Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review [1]
      Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis [1]
      Emergence of the Middle East Respiratory Syndrome Coronavirus [1]
      Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1 [1]
      Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients [1]
      Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant [1]
      End-Of-Life Care in the Time of COVID-19: Communication Matters More Than Ever [1]
      Ethical conflicts in COVID-19 times [1]
      Ethical dilemmas related to the covid-19 pandemic. A perspective. [Perspectiva de los dilemas éticos relacionados con la pandemia covid-19.] [1]
      Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform [1]
      Evaluation of COVID-19 vaccination strategies with a delayed second dose [1]
      Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization [1]
      Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses [1]